List of Dr. Reddy's Laboratories patents

Patents where

Current Assignee

Name

Dr. Reddy's Laboratories

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 9974770 Formulations comprising triptan compounds	Patent 9974770 was granted and assigned to Dr. Reddy's Laboratories on May, 2018 by the United States Patent and Trademark Office.	Dr. Reddy's Laboratories	Dr. Reddy's Laboratories	United States Patent and Trademark Office	9974770	May 22, 2018
‌ US Patent 11382923 Stable liquid formulations of cyclophosphamide and processes to prepare the same	Patent 11382923 was granted and assigned to Dr. Reddy's Laboratories on July, 2022 by the United States Patent and Trademark Office.	Dr. Reddy's Laboratories	Dr. Reddy's Laboratories	United States Patent and Trademark Office	11382923	July 12, 2022
‌ US Patent RE39266 Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases	Patent RE39266 was granted and assigned to Dr. Reddy's Laboratories on September, 2006 by the United States Patent and Trademark Office.		Dr. Reddy's Laboratories	United States Patent and Trademark Office	RE39266	September 5, 2006
‌ US Patent 9610280 Formulations comprising triptan compounds	Patent 9610280 was granted and assigned to Dr. Reddy's Laboratories on April, 2017 by the United States Patent and Trademark Office.	Dr. Reddy's Laboratories	Dr. Reddy's Laboratories	United States Patent and Trademark Office	9610280	April 4, 2017
‌ US Patent 11390583 Process for preparation of Siponimod, its salts and solid state forms thereof	Patent 11390583 was granted and assigned to Dr. Reddy's Laboratories on July, 2022 by the United States Patent and Trademark Office.	Dr. Reddy's Laboratories	Dr. Reddy's Laboratories	United States Patent and Trademark Office	11390583	July 19, 2022
‌ US Patent 10464933 Solid state forms of dasatinib and processes for their preparation	Patent 10464933 was granted and assigned to Dr. Reddy's Laboratories on November, 2019 by the United States Patent and Trademark Office.	Dr. Reddy's Laboratories	Dr. Reddy's Laboratories	United States Patent and Trademark Office	10464933	November 5, 2019
‌ US Patent 11364212 Methods for treating inflammatory skin conditions	Patent 11364212 was granted and assigned to Dr. Reddy's Laboratories on June, 2022 by the United States Patent and Trademark Office.		Dr. Reddy's Laboratories	United States Patent and Trademark Office	11364212	June 21, 2022
‌ US Patent 9926296 Process for the preparation of polymorphic forms of nilotinib hydrochloride	Patent 9926296 was granted and assigned to Dr. Reddy's Laboratories on March, 2018 by the United States Patent and Trademark Office.	Dr. Reddy's Laboratories	Dr. Reddy's Laboratories	United States Patent and Trademark Office	9926296	March 27, 2018
‌ US Patent 9211282 Formulations comprising triptan compounds	Patent 9211282 was granted and assigned to Dr. Reddy's Laboratories on December, 2015 by the United States Patent and Trademark Office.		Dr. Reddy's Laboratories	United States Patent and Trademark Office	9211282	December 15, 2015
‌ US Patent 11639391 Stable liquid pharmaceutical composition	Patent 11639391 was granted and assigned to Dr. Reddy's Laboratories on May, 2023 by the United States Patent and Trademark Office.	Dr. Reddy's Laboratories	Dr. Reddy's Laboratories	United States Patent and Trademark Office	11639391	May 2, 2023
‌ US Patent 9931328 Topical retinoid compositions	Patent 9931328 was granted and assigned to Dr. Reddy's Laboratories on April, 2018 by the United States Patent and Trademark Office.	Dr. Reddy's Laboratories	Dr. Reddy's Laboratories	United States Patent and Trademark Office	9931328	April 3, 2018
‌ US Patent 11292793 Solid dispersions of amorphous Lumateperone p-Tosylate	Patent 11292793 was granted and assigned to Dr. Reddy's Laboratories on April, 2022 by the United States Patent and Trademark Office.	Dr. Reddy's Laboratories	Dr. Reddy's Laboratories	United States Patent and Trademark Office	11292793	April 5, 2022
‌ US Patent 9655885 Amorphous mirabegron and processes for crystal forms of mirabegron	Patent 9655885 was granted and assigned to Dr. Reddy's Laboratories on May, 2017 by the United States Patent and Trademark Office.	Dr. Reddy's Laboratories	Dr. Reddy's Laboratories	United States Patent and Trademark Office	9655885	May 23, 2017
‌ US Patent 7223881 Process for the preparation of new antidiabetic agents	Patent 7223881 was granted and assigned to Dr. Reddy's Laboratories on May, 2007 by the United States Patent and Trademark Office.		Dr. Reddy's Laboratories	United States Patent and Trademark Office	7223881	May 29, 2007
‌ US Patent 10011590 Crystalline forms of vilazodone hydrochloride and vilazodone free base	Patent 10011590 was granted and assigned to Dr. Reddy's Laboratories on July, 2018 by the United States Patent and Trademark Office.	Dr. Reddy's Laboratories	Dr. Reddy's Laboratories	United States Patent and Trademark Office	10011590	July 3, 2018
‌ US Patent 9981947 Polymorphic forms of nilotinib hydrochloride	Patent 9981947 was granted and assigned to Dr. Reddy's Laboratories on May, 2018 by the United States Patent and Trademark Office.	Dr. Reddy's Laboratories	Dr. Reddy's Laboratories	United States Patent and Trademark Office	9981947	May 29, 2018
‌ US Patent 9051291 Process for producing (S)-equol	Patent 9051291 was granted and assigned to Dr. Reddy's Laboratories on June, 2015 by the United States Patent and Trademark Office.	Dr. Reddy's Laboratories	Dr. Reddy's Laboratories	United States Patent and Trademark Office	9051291	June 9, 2015
‌ US Patent 9040558 Substituted benzylamino quinolines as cholesterol ester-transfer protein inhibitors	Patent 9040558 was granted and assigned to Dr. Reddy's Laboratories on May, 2015 by the United States Patent and Trademark Office.		Dr. Reddy's Laboratories	United States Patent and Trademark Office	9040558	May 26, 2015
‌ US Patent 9782407 Substituted benzylamino quinolines as cholesterol ester-transfer protein inhibitors	Patent 9782407 was granted and assigned to Dr. Reddy's Laboratories on October, 2017 by the United States Patent and Trademark Office.	Dr. Reddy's Laboratories	Dr. Reddy's Laboratories	United States Patent and Trademark Office	9782407	October 10, 2017
‌ US Patent 8969558 Processes for the preparation of sitagliptin and pharmaceutically acceptable salts thereof	Patent 8969558 was granted and assigned to Dr. Reddy's Laboratories on March, 2015 by the United States Patent and Trademark Office.	Dr. Reddy's Laboratories	Dr. Reddy's Laboratories	United States Patent and Trademark Office	8969558	March 3, 2015
‌ US Patent 9879045 Processes for the preparation of dehydroepiandrosterone and its intermediates	Patent 9879045 was granted and assigned to Dr. Reddy's Laboratories on January, 2018 by the United States Patent and Trademark Office.	Dr. Reddy's Laboratories	Dr. Reddy's Laboratories	United States Patent and Trademark Office	9879045	January 30, 2018
‌ US Patent 11034675 Solid forms of Selinexor and process for their preparation	Patent 11034675 was granted and assigned to Dr. Reddy's Laboratories on June, 2021 by the United States Patent and Trademark Office.	Dr. Reddy's Laboratories	Dr. Reddy's Laboratories	United States Patent and Trademark Office	11034675	June 15, 2021
‌ US Patent 9688682 Crystalline forms of pemetrexed tromethamine salts	Patent 9688682 was granted and assigned to Dr. Reddy's Laboratories on June, 2017 by the United States Patent and Trademark Office.	Dr. Reddy's Laboratories	Dr. Reddy's Laboratories	United States Patent and Trademark Office	9688682	June 27, 2017
‌ US Patent 10293048 Pharmaceutical compositions comprising boronic acid compounds	Patent 10293048 was granted and assigned to Dr. Reddy's Laboratories on May, 2019 by the United States Patent and Trademark Office.	Dr. Reddy's Laboratories	Dr. Reddy's Laboratories	United States Patent and Trademark Office	10293048	May 21, 2019
‌ US Patent 10301353 Co-crystal of carfilzomib with maleic acid and process for the preparation of pure carfilzomib	Patent 10301353 was granted and assigned to Dr. Reddy's Laboratories on May, 2019 by the United States Patent and Trademark Office.	Dr. Reddy's Laboratories	Dr. Reddy's Laboratories	United States Patent and Trademark Office	10301353	May 28, 2019

Results per page:

75 results

0 selected

75 results

0 selected